What Is a GLP-1?

1. What Does GLP-1 Mean?

GLP-1 stands for glucagon-like peptide-1. NCBI MeSH describes it as a peptide derived from proglucagon and mainly produced by intestinal L cells. It affects glucose-dependent insulin release, glucagon release, gastric emptying, blood glucose, and food intake.

In everyday language, “GLP-1” is often used as shorthand for GLP-1 receptor agonist medications such as semaglutide or the dual GIP/GLP-1 receptor agonist tirzepatide. While common, this shorthand blurs the difference between the naturally occurring hormone and a prescribed drug product.

2. What Are GLP-1 Receptor Agonists?

GLP-1 receptor agonists are a medication class used for type 2 diabetes and, increasingly, obesity. Their mechanisms include stimulating insulin secretion after an oral glucose load, delaying gastric emptying, and reducing glucagon production when blood sugar is high.

While these mechanisms explain why the category appears in discussions about metabolic health and diabetes, each specific product has its own label, dosage, warnings, and prescribing context.

Peptide Tracker allows users to log specific medications-such as semaglutide, tirzepatide, Mounjaro, Zepbound, Wegovy, or Ozempic-exactly as entered, maintaining clear, accurate records of the specific product being used.

3. Why Does GLP-1 Get So Much Attention?

KFF reported in May 2024 that about one in eight U.S. adults had taken a GLP-1 agonist at some point, including 6% who were actively taking one. In that poll, 62% of people who had taken GLP-1 drugs said they used them at least partly for a chronic condition such as diabetes or heart disease.

Patients often use a tracker to manage the complexities of GLP-1 treatments, such as tracking product names, missed doses, side effects, and inventory. This keeps personal records organized and accurate for clinician conversations.

4. Why Do GLP-1 Records Mention Half-Life?

Half-life helps estimate medication timing and overlap, though it doesn’t measure individual blood levels. For example, DailyMed lists Wegovy’s (semaglutide) elimination half-life as approximately 1 week, noting it can remain in circulation for about 5 to 7 weeks after the last dose.

This is why a half-life chart may show overlap between logged entries. The chart is simply math based on a reference value-it is not a blood test or a replacement for medical dosing advice.

Peptide Tracker plots user-entered dose history against a standard reference half-life. Our peptide half-life tracking guide explains the formula and its limitations in more detail.

5. What Can a GLP-1 Tracker Record?

A GLP-1 tracker organizes essential data: dates, times, doses, product names, injection sites, side effects, and progress metrics.

Peptide Tracker supports dose logs, schedules, injection-site history, side-effect records, inventory, BAC water records, half-life visualization, progress photos, Apple Health imports, bloodwork logs, and PDF/CSV/TXT exports. It is designed entirely as a private recordkeeping tool, not a medical device or prescribing system.

6. What Is a GLP-1 FAQ

• What does GLP-1 stand for?

  GLP-1 stands for glucagon-like peptide-1, a peptide hormone derived from proglucagon and produced mainly by intestinal L cells.

• Are GLP-1 medications the same as natural GLP-1?

  No. Natural GLP-1 is a hormone. GLP-1 receptor agonist medications are drug products designed to activate related receptor pathways and differ in structure, duration, labeling, and approved uses.

• Can a GLP-1 tracker choose a dose?

  No. A GLP-1 tracker records user-entered logs, reminders, inventory, and notes. It cannot decide doses, timing, medical suitability, or product authenticity.

7. Sources